TY - JOUR
T1 - Functional evidence for an apical ANP receptor in LLC-PK1 kidney epithelial cells
AU - Yukiya Hashimoto, Hashimoto
AU - Junko Ozaki, Ozaki
AU - Masato Yasuhara, Yasuhara
AU - Ryohei Hori, Hori
AU - Shin-ichi Suga, Suga
AU - Hiroshi Itoh, Itoh
AU - Kazuwa Nakao, Nakao
AU - Ken-inchi Inui, Inui
N1 - Funding Information:
This work was supporteidn part by a Grant-in-Aidfo r Scientific Researchfr om the Ministry of EducationS, cience,a nd Culture of Japan.
PY - 1994/8/16
Y1 - 1994/8/16
N2 - The localization of natriuretic peptide receptors was studied in LLC-PK1 cell monolayers grown on a micro-porous membrane filter. The addition of α-human atrial natriuretic peptide (α-hANP) to the apical side of the cells produced a concentration-dependent increase in cyclic GMP (cGMP) formation, the extent of which was similar to that produced by the addition to the basolateral side. More cGMP was formed with α-hANP (1 and 100 nM) than with the C-type natriuretic peptide (100 nM). These findings indicate that the biologically active receptors with high efficacy for α-hANP are expressed in both the apical and basolateral membranes in LLC-PK1 cells.
AB - The localization of natriuretic peptide receptors was studied in LLC-PK1 cell monolayers grown on a micro-porous membrane filter. The addition of α-human atrial natriuretic peptide (α-hANP) to the apical side of the cells produced a concentration-dependent increase in cyclic GMP (cGMP) formation, the extent of which was similar to that produced by the addition to the basolateral side. More cGMP was formed with α-hANP (1 and 100 nM) than with the C-type natriuretic peptide (100 nM). These findings indicate that the biologically active receptors with high efficacy for α-hANP are expressed in both the apical and basolateral membranes in LLC-PK1 cells.
KW - ANP (atrial natriuretic peptide)
KW - Guanylate cyclase
KW - LLC-PK cell
KW - Natriuretic peptide, C-type
UR - http://www.scopus.com/inward/record.url?scp=0028169675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028169675&partnerID=8YFLogxK
U2 - 10.1016/0922-4106(94)90071-X
DO - 10.1016/0922-4106(94)90071-X
M3 - Article
C2 - 7805770
AN - SCOPUS:0028169675
SN - 0922-4106
VL - 268
SP - 443
EP - 445
JO - European Journal of Pharmacology: Molecular Pharmacology
JF - European Journal of Pharmacology: Molecular Pharmacology
IS - 3
ER -